Search research articles
Contact Us
Filters
Showing results (21-30 of 65) with videos related to
Page
of 7
Sort By:
Psychotherapy and Psychosomatics
|
November 18, 2025
Placebo Effect of Verbal Instructions Coupled with Pharmacological Treatment: Results from a Randomized Controlled Trial in Migraine Patients
Sara Romanazzo, Francesca Monti, Sara Ceccatelli, et al.
CNS Spectrums
|
July 27, 2021
Mental pain as a global person-centered outcome measure
Fiammetta Cosci, Giovanni Mansueto, Silvia Benemei, et al.
European Journal of Neurology
|
January 31, 2022
Predictors of sustained response and effects of the discontinuation of anti-calcitonin gene related peptide antibodies and reinitiation in resistant chronic migraine
Luigi Francesco Iannone, Davide Fattori, Silvia Benemei, et al.
Headache
|
May 27, 2026
Beyond symptom: Exploring the analgesic properties of vomiting in patients with migraine
Antonio Munafò, Andrea Burgalassi, Giulia Vigani, et al.
Cephalalgia : an International Journal of Headache
|
July 1, 2022
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine
Luigi Francesco Iannone, Francesco De Cesaris, Anita Ferrari, et al.
CNS Drugs
|
February 11, 2022
Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score
Luigi Francesco Iannone, Davide Fattori, Silvia Benemei, et al.
CNS Spectrums
|
October 29, 2019
Criterion-related validity in a sample of migraine outpatients: the diagnostic criteria for psychosomatic research
Fiammetta Cosci, Andrea Svicher, Sara Romanazzo, et al.
Cephalalgia : an International Journal of Headache
|
March 15, 2023
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study
Luigi Francesco Iannone, Andrea Burgalassi, Giulia Vigani, et al.
Headache
|
October 13, 2023
Patterns of anti-CGRP mAbs use and variation of triptan consumption following treatment initiation: A descriptive drug utilization study in the Tuscany region, Italy
Giulia Hyeraci, Olga Paoletti, Luigi Francesco Iannone, et al.
CNS Drugs
|
January 19, 2023
Switching OnabotulinumtoxinA to Monoclonal Anti-CGRP Antibodies in Drug-Resistant Chronic Migraine
Luigi Francesco Iannone, Davide Fattori, Martina Marangoni, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 65) with videos related to
Sort By:
Page
of 7
Psychotherapy and Psychosomatics
|
November 18, 2025
Placebo Effect of Verbal Instructions Coupled with Pharmacological Treatment: Results from a Randomized Controlled Trial in Migraine Patients
Sara Romanazzo, Francesca Monti, Sara Ceccatelli, et al.
CNS Spectrums
|
July 27, 2021
Mental pain as a global person-centered outcome measure
Fiammetta Cosci, Giovanni Mansueto, Silvia Benemei, et al.
European Journal of Neurology
|
January 31, 2022
Predictors of sustained response and effects of the discontinuation of anti-calcitonin gene related peptide antibodies and reinitiation in resistant chronic migraine
Luigi Francesco Iannone, Davide Fattori, Silvia Benemei, et al.
Headache
|
May 27, 2026
Beyond symptom: Exploring the analgesic properties of vomiting in patients with migraine
Antonio Munafò, Andrea Burgalassi, Giulia Vigani, et al.
Cephalalgia : an International Journal of Headache
|
July 1, 2022
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine
Luigi Francesco Iannone, Francesco De Cesaris, Anita Ferrari, et al.
CNS Drugs
|
February 11, 2022
Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score
Luigi Francesco Iannone, Davide Fattori, Silvia Benemei, et al.
CNS Spectrums
|
October 29, 2019
Criterion-related validity in a sample of migraine outpatients: the diagnostic criteria for psychosomatic research
Fiammetta Cosci, Andrea Svicher, Sara Romanazzo, et al.
Cephalalgia : an International Journal of Headache
|
March 15, 2023
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study
Luigi Francesco Iannone, Andrea Burgalassi, Giulia Vigani, et al.
Headache
|
October 13, 2023
Patterns of anti-CGRP mAbs use and variation of triptan consumption following treatment initiation: A descriptive drug utilization study in the Tuscany region, Italy
Giulia Hyeraci, Olga Paoletti, Luigi Francesco Iannone, et al.
CNS Drugs
|
January 19, 2023
Switching OnabotulinumtoxinA to Monoclonal Anti-CGRP Antibodies in Drug-Resistant Chronic Migraine
Luigi Francesco Iannone, Davide Fattori, Martina Marangoni, et al.
Page
of 7